Priority Health Medicaid · Zepbound and Wegovy coverage

Does Priority Health Medicaid cover Zepbound or Wegovy?

Last updated

Michigan Medicaid's stricter weight-loss GLP-1 criteria apply since January 1, 2026.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Michigan Medicaid's stricter weight-loss GLP-1 criteria apply since January 1, 2026. Saxenda, Wegovy and Zepbound for weight loss come under stricter coverage and criteria for every Michigan Medicaid member from January 1, 2026. In its words: "Effective Jan. 1, 2026, coverage and criteria of GLP-1 weight-loss drugs Saxenda, Wegovy and Zepbound will become more restrictive for all Michigan Medicaid members." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Michigan's 2026 budget law required the change. In its words: "The State of Michigan fiscal year 2026 budget made a law that required Michigan Medicaid to further restrict coverage of GLP-1 weight-loss drugs; Saxenda, Wegovy, and Zepbound." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Members already approved keep coverage until their current approval ends, and a renewal has to meet the new criteria. In its words: "Medicaid members who are currently approved for a GLP-1 weight-loss drug will have continued coverage through the end of their current authorization. Upon renewal, members will need to meet the new criteria to continue with coverage." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026).

Questions

Priority Health Medicaid, Zepbound and Wegovy: common questions

Does Priority Health Medicaid cover Zepbound for weight loss?

Michigan Medicaid's stricter weight-loss GLP-1 criteria apply since January 1, 2026. Saxenda, Wegovy and Zepbound for weight loss come under stricter coverage and criteria for every Michigan Medicaid member from January 1, 2026. In its words: "Effective Jan. 1, 2026, coverage and criteria of GLP-1 weight-loss drugs Saxenda, Wegovy and Zepbound will become more restrictive for all Michigan Medicaid members." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Michigan's 2026 budget law required the change. In its words: "The State of Michigan fiscal year 2026 budget made a law that required Michigan Medicaid to further restrict coverage of GLP-1 weight-loss drugs; Saxenda, Wegovy, and Zepbound." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Members already approved keep coverage until their current approval ends, and a renewal has to meet the new criteria. In its words: "Medicaid members who are currently approved for a GLP-1 weight-loss drug will have continued coverage through the end of their current authorization. Upon renewal, members will need to meet the new criteria to continue with coverage." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Zepbound not covered: the cash price at your dose

Does Priority Health Medicaid cover Wegovy for weight loss?

Michigan Medicaid's stricter weight-loss GLP-1 criteria apply since January 1, 2026. Saxenda, Wegovy and Zepbound for weight loss come under stricter coverage and criteria for every Michigan Medicaid member from January 1, 2026. In its words: "Effective Jan. 1, 2026, coverage and criteria of GLP-1 weight-loss drugs Saxenda, Wegovy and Zepbound will become more restrictive for all Michigan Medicaid members." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Michigan's 2026 budget law required the change. In its words: "The State of Michigan fiscal year 2026 budget made a law that required Michigan Medicaid to further restrict coverage of GLP-1 weight-loss drugs; Saxenda, Wegovy, and Zepbound." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Members already approved keep coverage until their current approval ends, and a renewal has to meet the new criteria. In its words: "Medicaid members who are currently approved for a GLP-1 weight-loss drug will have continued coverage through the end of their current authorization. Upon renewal, members will need to meet the new criteria to continue with coverage." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026). Wegovy not covered: the cash price at your dose

Does Michigan Medicaid cover Wegovy or Zepbound for weight loss?

Yes, but narrowly: Michigan Medicaid is one of the 13 programs KFF counted covering GLP-1s for obesity treatment as of January 2026 (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026), and its own criteria, effective Jan 1, 2026, say: "GLP-1 product coverage requested for treatment of obesity will require additional clinical PA requirements such as the following: Patient must be classified as morbidly obese; and Coverage is contingent on documented failure of all other clinically appropriate weight-loss interventions" (Michigan MDHHS letter L 25-73, michigan.gov, read Nov 17, 2026). Utah, Massachusetts, and Rhode Island have ended theirs since, by their own notices, and Michigan is not among them. Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively". Michigan Medicaid and GLP-1s: the state's words, and the cash price

Is Priority Health Medicaid dropping GLP-1 coverage for weight loss?

Michigan Medicaid's stricter weight-loss GLP-1 criteria apply since January 1, 2026. Saxenda, Wegovy and Zepbound for weight loss come under stricter coverage and criteria for every Michigan Medicaid member from January 1, 2026. In its words: "Effective Jan. 1, 2026, coverage and criteria of GLP-1 weight-loss drugs Saxenda, Wegovy and Zepbound will become more restrictive for all Michigan Medicaid members." (Priority Health, GLP-1 Weight-loss drug coverage changes coming for Medicaid members (Dec 15, 2025), priorityhealth.com, read Nov 20, 2026).

What do Zepbound and Wegovy cost if Priority Health Medicaid does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership) among sellers that serve Michigan; compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership) among sellers that serve Michigan. Every GLP-1's cash price without insurance

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.